Name of opportunity: 👀
Rigel Pharmaceuticals Inc
KFDA Approval ✅
Rigel Pharmaceuticals have developed an innovative therapy, Tavalisse, to treat Immune thrombocytopenia, which is a rare platelet disorder. Approved in the USA in 2018, the Korean Food and Drug Administration (KFDA) has now also announced approval of this therapy, meaning that the treatment can now be rolled out across this market.
This news is great for investors and those thinking about investing in Rigel Pharmaceuticals as it showcases the company’s success and innovation within the world of pharmaceuticals.
Analysts are currently calling Rigel Pharmaceuticals a ‘buy’.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of Rigel Pharmaceuticals Inc might increase from $20.13 to $44.08 in the next 12 months. If you invested $1000, you might profit $1189.93.
Rigel Pharmaceuticals is a growth stock, meaning it reinvests its profits to grow the business. The company currently has healthy cash flow and strong gross margin, which indicates solid financial performance.
The stock is up 16.01% in the past day, and 15.03% in the past week, this surge might be to do with the recent KDFA announcement. Rigel Pharmaceuticals also experienced a lot of commercial success in 2024, with sales of Tavalisse and Rezlidhia at a record high, as well as the transfer of U.S. rights with drug Gevrato. These drugs have all skyrocketed Rigel’s revenue, boosting investor confidence from this recent success.
Additionally, Rigel Pharmaceuticals have recently commented on its 2025 financial outlook, and it looks promising. The company is expecting a total revenue of around $200 to $210 million in 2025, with plans to fund new clinical development programs as well as existing ones.
Biotechnology company 🧬
Rigel Pharmaceuticals Inc is an American biotechnology company that is headquartered in South San Francisco, California, United States. The company specialises in developing novel therapies to improve the lives of patients with cancer and hematologic disorders.
Which neme?: 🔍
‘Top Gainers Today’, ‘Stocks On The Move’.
Download Nemo Money to check out Rigel Pharmaceuticals Inc. New users can grab our registration bonus up to a maximum of $50 on first deposit. Terms and conditions apply.
